Loading data
MELINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.34 bn USD | 15.14 bn USD | 10.49 bn USD | 7.45 bn USD | 5.71 bn USD |
| Cost of revenue | 16.04 bn USD | 11.2 bn USD | 7.52 bn USD | 5.58 bn USD | 4.06 bn USD |
| Gross profit | 12.86 bn USD | 9.58 bn USD | 7.59 bn USD | 5.2 bn USD | 3.01 bn USD |
| Research and development expense | 2.27 bn USD | 1.93 bn USD | 1.83 bn USD | 1.1 bn USD | 590 m USD |
| Operating profit | 3.2 bn USD | 2.63 bn USD | 2.21 bn USD | 1.07 bn USD | 441 m USD |
| Profit before tax | 2.84 bn USD | 2.43 bn USD | 1.55 bn USD | 780 m USD | 241 m USD |
| Income tax expense | 845 m USD | 521 m USD | 569 m USD | 298 m USD | 149 m USD |
| Net income (reported basis) | 2 bn USD | 1.91 bn USD | 987 m USD | 482 m USD | 83 m USD |
| Net income attributable to common shareholders | — | 1.91 bn USD | 987 m USD | 482 m USD | 83 m USD |
| Basic earnings per share | 39.4 USD/share | 37.69 USD/share | 19.64 USD/share | 9.57 USD/share | 1.67 USD/share |
| Diluted earnings per share | 39.4 USD/share | 37.69 USD/share | 19.46 USD/share | 9.53 USD/share | 1.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.